Clinical Trial Update: Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dupilumab in persistent asthma has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-10-23